Dec 01, 2020 / 07:40PM GMT
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Excellent. Thank you all for joining us. Pleasure to have the management team from Lilly join us today. We have Mike from the -- heading the diabetes business. We have Kevin and Sara from the Investor Relations team. And we also have, most importantly, Mike DiFiore from my team as well. So we're all on. Thank you guys for being here.
There's a lot to talk about. And I think, Kevin, correct me if I'm wrong, but the goal today was to only talk oncology, correct?
Michael B. Mason - Eli Lilly and Company - Senior VP & President of Lilly Diabetes
It's going to be a short call.
Kevin Hern - Eli Lilly and Company - VP of IR
If you could fill in a little bit -- Mike would love to do Alzheimer's as well, if you have...
Michael B. Mason - Eli Lilly and Company - Senior VP & President of Lilly Diabetes
Yes, yes. And a little bit of COVID, too, why
Eli Lilly and Co at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 02, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers